BIA
Biondo Investment Advisors Portfolio holdings
AUM
$759M
1-Year Return
16.64%
This Quarter Return
-1.18%
1 Year Return
+16.64%
3 Year Return
+102.11%
5 Year Return
+165.96%
10 Year Return
+637.5%
AUM
$391M
AUM Growth
-$30.5M
(-7.2%)
Cap. Flow
-$19.2M
Cap. Flow
% of AUM
-4.9%
Top 10 Holdings %
Top 10 Hldgs %
48.1%
Holding
93
New
5
Increased
41
Reduced
33
Closed
7
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$3.36M |
| 2 |
Boeing
BA
|
$1.07M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$465K |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$464K |
| 5 |
Edwards Lifesciences
EW
|
$389K |
Top Sells
| 1 |
Mastercard
MA
|
$7.45M |
| 2 |
Under Armour
UAA
|
$5.07M |
| 3 |
Exact Sciences
EXAS
|
$4.57M |
| 4 |
Dorman Products
DORM
|
$2.13M |
| 5 |
Intuitive Surgical
ISRG
|
$1.61M |
Sector Composition
| 1 | Healthcare | 34.12% |
| 2 | Technology | 18.35% |
| 3 | Financials | 13.13% |
| 4 | Consumer Discretionary | 7.6% |
| 5 | Communication Services | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Salesforce
CRM
$233B
| $4.84M | 1.24% |
32,587
-50
| -0.2% | -$7.42K |
|
27
Johnson & Johnson
JNJ
$430B
| $4.79M | 1.23% |
36,778
-545
| -1% | -$71K |
|
|
SIVB
28
DELISTED
SVB Financial Group
SIVB
| $4.77M | 1.22% |
22,840
-910
| -4% | -$190K |
|
29
Duke Energy
DUK
$94B
| $4.66M | 1.19% |
48,093
+63
| +0.1% | +$6.1K |
|
30
Atlassian
TEAM
$44.1B
| $4.58M | 1.17% |
36,475
+1,250
| +4% | +$157K |
|
31
AbbVie
ABBV
$376B
| $4.54M | 1.16% |
60,014
-907
| -1% | -$68.7K |
|
32
Exxon Mobil
XOM
$479B
| $4.53M | 1.16% |
63,432
-245
| -0.4% | -$17.5K |
|
33
Alibaba
BABA
$312B
| $4.35M | 1.11% |
26,019
+156
| +0.6% | +$26.1K |
|
34
3M
MMM
$82.9B
| $4.29M | 1.1% |
30,935
+253
| +0.8% | +$35.1K |
|
35
General Mills
GIS
$26.5B
| $4.15M | 1.06% |
75,314
+228
| +0.3% | +$12.6K |
|
36
Align Technology
ALGN
$9.75B
| $3.87M | 0.99% |
21,384
-409
| -2% | -$74K |
|
37
AT&T
T
$212B
| $3.8M | 0.97% |
132,793
+764
| +0.6% | +$21.8K |
|
|
38
Iovance Biotherapeutics
IOVA
$796M
| $3.36M | 0.86% |
+184,835
| New | +$3.36M |
|
39
Amazon
AMZN
$2.51T
| $3.28M | 0.84% |
37,740
+100
| +0.3% | +$8.68K |
|
40
Bristol-Myers Squibb
BMY
$95B
| $3.2M | 0.82% |
63,163
+860
| +1% | +$43.6K |
|
41
Truist Financial
TFC
$60.7B
| $3.05M | 0.78% |
56,680
+365
| +0.6% | +$19.6K |
|
42
Altria Group
MO
$112B
| $2.61M | 0.67% |
63,859
-440
| -0.7% | -$18K |
|
|
ICPT
43
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.5M | 0.64% |
37,734
-339
| -0.9% | -$22.5K |
|
44
Twilio
TWLO
$16.3B
| $2.5M | 0.64% |
22,750
-45
| -0.2% | -$4.95K |
|
45
DuPont de Nemours
DD
$32.3B
| $1.79M | 0.46% |
24,976
+747
| +3% | +$53.5K |
|
46
Alphabet (Google) Class C
GOOG
$2.81T
| $1.46M | 0.37% |
23,960
-400
| -2% | -$24.4K |
|
47
iShares Core High Dividend ETF
HDV
$11.6B
| $1.36M | 0.35% |
14,445
+265
| +2% | +$25K |
|
|
AMRN
48
Amarin Corp
AMRN
$310M
| $1.3M | 0.33% |
4,283
+1,533
| +56% | +$465K |
|
|
49
Edwards Lifesciences
EW
$47.5B
| $1.18M | 0.3% |
16,080
+5,310
| +49% | +$389K |
|
50
Amgen
AMGN
$151B
| $1.09M | 0.28% |
5,609
+24
| +0.4% | +$4.68K |
|